High PRDM16 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk: a comprehensive cohort study from a single Chinese center-Reference-Cited by-同舟云学术

High PRDM16 expression predicts poor outcomes in adult acute myeloid leukemia patients with intermediate cytogenetic risk: a comprehensive cohort study from a single Chinese center

Published:2020-09-09 Issue:1 Volume:62 Page:185-193
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Dao Feng-Ting¹,Chen Wen-Min¹,Long Ling-Yu¹,Li Ling-Di¹,Yang Lu¹,Wang Jun¹,Liu Yan-Rong¹,Jiang Hao¹,Zhang Xiao-Hui¹,Jiang Qian¹,Qin Ya-Zhen¹

Affiliation:

1. Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Funder

National Nature Science Foundation of China

Peking University People’s Hospital Research and Development Funds

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1817436

Reference34 articles.

1. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial

2. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study